O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1-Reference-Cited by-同舟云学术

O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1

Published:2016-01 Issue: Volume:108 Page:564-576
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Malachowski William P.^ORCID,Winters Maria,DuHadaway James B.^ORCID,Lewis-Ballester Ariel,Badir Shorouk,Wai Jenny,Rahman Maisha,Sheikh Eesha,LaLonde Judith M.,Yeh Syun-Ru,Prendergast George C.,Muller Alexander J.

Funder

National Institutes of Health

Susan G. Komen for the Cure

Charlotte Geyer Foundation

Lankenau Hospital Foundation

National Science Foundation

Bryn Mawr College

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference58 articles.

1. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion;Schreiber;Science,2011

2. The immunobiology of cancer immunosurveillance and immunoediting;Dunn;Immunity,2004

3. Immunosuppressive networks in the tumour environment and their therapeutic relevance;Zou;Nat. Rev. Cancer,2005

4. Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors;Muller;Nat. Rev. Cancer,2006

5. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan;Metz;Cancer Res.,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of 2-benzylsulfinyl-benzoxazoles as potent and selective indoleamine 2,3-dioxygenase 1 inhibitors to combat inflammation;Bioorganic Chemistry;2024-11

2. Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors;Bioorganic Chemistry;2024-07

3. Inhibition of kynurenine production by N,O-substituted hydroxylamine derivatives;Bioorganic & Medicinal Chemistry Letters;2024-07

4. N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H;Molecules;2024-06-20

5. Novel compounds with promising IDO1 inhibitory activity as new cancer drug candidates: Derivatives of N,N'-diphenylurea linked with 1,2,3-triazole;PHARMAZIE;2023